CROs/Service Providers

Repligen acquires Novozymes business for $23 million

Friday, October 28, 2011 02:06 PM

Repligen has acquired the business of Novozymes Biopharma Sweden in a cash $22.7 million and future potential milestone payments of $5.6 million. This acquisition will elevate Repligen to a world-leading supplier of products for manufacturing biologic drugs with the potential to yield sustainable growth and profitability in fiscal year 2013, beginning April 1, 2012. The combined company is expected to generate total revenues of approximately $50 million in fiscal year 2013.

More... »

Protagen, Charles River form marketing alliance

Friday, October 28, 2011 10:39 AM

Protagen and Charles River Laboratories International have formed a strategic marketing & sales alliance.

More... »

Parexel expands commercialization services

Thursday, October 27, 2011 01:14 PM

Parexel International has expanded its capabilities to provide biopharmaceutical companies with dedicated support for their commercialization goals.  PAREXEL has fully integrated its commercialization services to help clients maximize regional and global market access opportunities. These solutions align reimbursement strategies with clinical development to gather the precise data required to demonstrate product value.

More... »

Quintiles to acquire Advion BioServices

Wednesday, October 26, 2011 12:01 PM

Quintiles has agreed to buy Advion BioServices, a 19-year-old bioanalytical lab that recently penned a strategic partnership with Eli Lilly.

More... »

WuXi PharmaTech acquires two clinical research companies in China

Monday, October 24, 2011 11:44 AM

WuXi PharmaTech has acquired MedKey Med-Tech Development and Jiecheng Med-Tech Development, two related contract clinical research services companies based in Shanghai, China. The financial terms of the transaction were not disclosed.

More... »

ShangPharma acquires Charles River’s Shanghai facility

Monday, October 24, 2011 10:49 AM

ShangPharma, a China-based pharmaceutical and biotechnology research and development outsourcing company, has acquired the assets in Charles River Laboratories International’s Shanghai research facility.

More... »

CenterWatch, Plutus Capital launch Clinical Trials Quarterly

Monday, October 24, 2011 10:37 AM

CenterWatch and Plutus Capital Partners have launched Clinical Trials Quarterly, a co-branded newsletter for the contract research organization (CRO) industry that expands CenterWatch’s reach to financial clients in Asia and Europe.

More... »

Goodwin Biotech collaborates with Spectros

Monday, October 24, 2011 10:31 AM

Goodwin Biotechnology and Spectros have reported a collaboration for the process development and cGMP manufacturing of an antibody: dye conjugate that will be used in phase I and phase II clinical trials.

More... »

Survey: Top CROs doubled workforce over past decade

Monday, October 24, 2011 08:02 AM

Over the last 10 years, the top nine global CROs have more than doubled their workforce, which now exceeds 72,000 employees, and their revenues have increased at a compound annualized rate of 11% as they increasingly play a larger and more integral role in the drug development infrastructure, according to a new Association of Clinical Research Organizations (ACRO) member survey.

More... »

IRX Therapeutics relocates creating 280 jobs in Florida

Friday, October 21, 2011 12:08 PM

St. Petersburg, Fla. - Gov. Rick Scott has reported the relocation of IRX Therapeutics, a clinical stage biotechnology company, to St. Petersburg from New York City by the year's end.  The company will staff more than 280 positions within five years at a projected minimum average wage of $90,000 annually.

More... »